Return
Prevalence and outcomes of real-world bipolar depression patients underrepresented in guideline RCTs
M
C
V
E
E
G
A
R
F
A
DOI:10.1016/j.jad.2026.122363.png)
Abstract
En 中文
• Existing guidelines such as the CANMAT/ISBD inform the pharmacotherapy of acute bipolar depression. • Real-world patients with bipolar depression are nonetheless hard to capture by existing guidelines. • Real-world bipolar depression patients warrant systematic appraisal.
Journal
IF:
4.9
Papers:
2.1W
Citations:
6.9W
